Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksIpca Laboratories shares fall 2.07% in today's trading

    Ipca Laboratories shares fall 2.07% in today's trading

    With the stock's last traded price at Rs 1,370.30, Ipca Laboratories has seen a decline of 2.07% today.

    Alpha Desk
    September 23, 2025 / 12:37 IST
    Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Shares of Ipca Laboratories declined by 2.07%, trading at Rs 1,370.30 on Tuesday. The stock is a constituent of the Nifty Midcap 150 index.

      Financial Performance:

      Ipca Laboratories has demonstrated consistent financial performance. The consolidated revenue for the quarter-ending June 2025 stood at Rs 2,308.85 Crore, compared to Rs 2,092.63 Crore in June 2024. The net profit for the same period was Rs 234.42 Crore, up from Rs 198.98 Crore in the previous year.

      Quarterly Financials:

      HeadingJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
      RevenueRs 2,092.63 CroreRs 2,354.90 CroreRs 2,245.37 CroreRs 2,246.69 CroreRs 2,308.85 Crore
      Net ProfitRs 198.98 CroreRs 245.44 CroreRs 277.33 CroreRs 65.78 CroreRs 234.42 Crore
      EPS7.589.059.782.679.19

      The consolidated revenue for the year-ending March 2025 was Rs 8,939.59 Crore, a notable increase from Rs 7,705.04 Crore in the previous year. Net profit for the year-ending March 2025 stood at Rs 787.53 Crore compared to Rs 529.21 Crore in March 2024. Earnings per share (EPS) increased to Rs 35.14 in March 2025 from Rs 25.82 in March 2024.

      Yearly Financials:

      Heading20212022202320242025
      RevenueRs 5,419.99 CroreRs 5,829.79 CroreRs 6,244.32 CroreRs 7,705.04 CroreRs 8,939.59 Crore
      Net ProfitRs 1,148.84 CroreRs 910.95 CroreRs 491.93 CroreRs 529.21 CroreRs 787.53 Crore
      EPS45.0134.8518.5825.8235.14
      BVPS371.79219.51233.16304.57273.88
      ROE24.2416.098.068.6410.61
      Debt to Equity0.050.140.250.220.19
      Income Statement:
      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      SalesRs 8,939 CroreRs 7,705 CroreRs 6,244 CroreRs 5,829 CroreRs 5,419 Crore
      Other IncomeRs 92 CroreRs 124 CroreRs 125 CroreRs 66 CroreRs 62 Crore
      Total IncomeRs 9,032 CroreRs 7,829 CroreRs 6,369 CroreRs 5,896 CroreRs 5,482 Crore
      Total ExpenditureRs 7,816 CroreRs 6,848 CroreRs 5,579 CroreRs 4,752 CroreRs 4,084 Crore
      EBITRs 1,216 CroreRs 980 CroreRs 790 CroreRs 1,143 CroreRs 1,398 Crore
      InterestRs 84 CroreRs 138 CroreRs 45 CroreRs 7 CroreRs 9 Crore
      TaxRs 343 CroreRs 313 CroreRs 253 CroreRs 224 CroreRs 240 Crore
      Net ProfitRs 787 CroreRs 529 CroreRs 491 CroreRs 910 CroreRs 1,148 Crore
      Cash Flow:
      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Operating ActivitiesRs 1,321 CroreRs 944 CroreRs 805 CroreRs 856 CroreRs 1,090 Crore
      Investing ActivitiesRs -869 CroreRs -1,291 CroreRs -725 CroreRs -855 CroreRs -520 Crore
      Financing ActivitiesRs -282 CroreRs -552 CroreRs 507 CroreRs 426 CroreRs -305 Crore
      OthersRs 0 CroreRs 76 CroreRs 0 CroreRs 4 CroreRs 0 Crore
      Net Cash FlowRs 168 CroreRs -823 CroreRs 588 CroreRs 431 CroreRs 263 Crore
      Balance Sheet:
      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Share CapitalRs 25 CroreRs 25 CroreRs 25 CroreRs 25 CroreRs 25 Crore
      Reserves & SurplusRs 6,923 CroreRs 6,306 CroreRs 5,816 CroreRs 5,466 CroreRs 4,676 Crore
      Current LiabilitiesRs 2,386 CroreRs 2,355 CroreRs 1,805 CroreRs 1,465 CroreRs 1,160 Crore
      Other LiabilitiesRs 2,425 CroreRs 2,413 CroreRs 978 CroreRs 681 CroreRs 206 Crore
      Total LiabilitiesRs 11,760 CroreRs 11,101 CroreRs 8,626 CroreRs 7,638 CroreRs 6,068 Crore
      Fixed AssetsRs 4,798 CroreRs 4,805 CroreRs 2,853 CroreRs 2,669 CroreRs 2,260 Crore
      Current AssetsRs 6,268 CroreRs 5,538 CroreRs 5,189 CroreRs 4,457 CroreRs 3,436 Crore
      Other AssetsRs 694 CroreRs 756 CroreRs 583 CroreRs 511 CroreRs 370 Crore
      Total AssetsRs 11,760 CroreRs 11,101 CroreRs 8,626 CroreRs 7,638 CroreRs 6,068 Crore
      Contingent LiabilitiesRs 613 CroreRs 303 CroreRs 2,125 CroreRs 274 CroreRs 369 Crore
      Ratios:
      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Basic EPS (Rs.)35.1425.8218.5834.8545.01
      Diluted Eps (Rs.)29.0821.5718.5834.8545.01
      Book Value /Share (Rs.)273.88304.57233.16219.51371.79
      Dividend/Share (Rs.)4.004.004.004.008.00
      Face Value11112
      Gross Profit Margin (%)20.3418.7616.8523.5929.65
      Operating Margin (%)15.8914.1212.6619.6125.79
      Net Profit Margin (%)8.806.867.8715.6221.19
      Return on Networth / Equity (%)10.618.648.0616.0924.24
      ROCE (%)15.1512.4411.5918.5228.48
      Return On Assets (%)6.274.935.4611.5718.78
      Current Ratio (X)2.632.352.873.042.96
      Quick Ratio (X)1.551.301.911.771.59
      Debt to Equity (x)0.190.220.250.140.05
      Interest Coverage Ratios (X)21.4210.4623.11178.91177.79
      Asset Turnover Ratio (%)0.780.780.770.800.91
      Inventory Turnover Ratio (X)3.551.050.950.961.10
      3 Yr CAGR Sales (%)23.8319.2315.9024.3028.99
      3 Yr CAGR Net Profit (%)-7.02-32.13-10.3043.23117.14
      P/E (x)42.7447.9243.6130.5821.15
      P/B (x)5.484.963.524.905.13
      EV/EBITDA (x)22.2623.4519.2319.7314.96
      P/S (x)4.264.083.294.624.45
      Corporate Actions:

      Ipca Laboratories announced the closure of the trading window, as per an announcement on September 22, 2025. Other corporate actions include relodgement of transfer requests for physical shares and newspaper publications. The company has announced a final dividend of Rs 2.00 per share (200%) on May 29, 2025, with an effective date of August 05, 2025. It also announced an interim dividend of Rs 2.00 per share (200%) on October 24, 2024, which was revised with an effective date of November 25, 2024. The company had a bonus issue of 1:1, with the ex-bonus date on January 28, 2005. A stock split occurred on January 10, 2022, with the face value changing from Rs 2 to Rs 1.

      Moneycontrol analysis, as of September 19, 2025, suggests a very bullish sentiment on the stock.

      With the stock's last traded price at Rs 1,370.30, Ipca Laboratories has seen a decline of 2.07% today.

      Alpha Desk
      first published: Sep 23, 2025 12:37 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347